Cover ImageSALE
市場調查報告書

免疫蛋白質診斷檢驗的全球市場:2017年∼2021年

Global Immunoprotein Diagnostic Testing Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 347452
出版日期 內容資訊 英文 96 Pages
訂單完成後即時交付
價格
Back to Top
免疫蛋白質診斷檢驗的全球市場:2017年∼2021年 Global Immunoprotein Diagnostic Testing Market 2017-2021
出版日期: 2017年09月22日 內容資訊: 英文 96 Pages
簡介

全球免疫蛋白質診斷檢驗市場,預計2017年∼2021年以7.89%的年複合成長率成長。

本報告提供全球免疫蛋白質診斷檢驗市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 調查範圍

第3章 市場調查手法

第4章 簡介

  • 市場趨勢的概要

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 市場區隔:各應用

  • 概要
  • 傳染病檢查
  • 腫瘤、內分泌檢查
  • 自體免疫檢驗
  • 過敏檢驗

第7章 市場區隔:各終端用戶

  • 概要
  • 醫院、診療所
  • 臨床檢驗室

第8章 地理區分

  • 概要
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區市場

第9章 決策結構

第10章 市場的推動要素與課題

第11章 市場趨勢

第12章 業者情勢

  • 競爭模式

第13章 主要供應商分析

  • Beckman Coulter
  • DiaSorin
  • F. Hoffmann-La Roche
  • Siemens Healthcare
  • 值得注意的企業
  • 其他卓越供應商

第14章 附錄

  • 簡稱清單

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR14698

About Immunoprotein Diagnostic Testing

Immunoproteins are blood proteins that act as the body's defense mechanism. They also play a major role in the functioning of the immune system. Immunoprotein diagnostic testing helps detect several diseases such as cancers, allergies, influenza, and other autoimmune diseases. The concentration of immunoproteins within the body is used as an indicator to diagnose diseases. Based on application, the global immunoprotein diagnostic testing market has been segmented into infectious disease testing, allergy testing, oncology and endocrinology testing, and autoimmune testing.

Technavio's analysts forecast the global immunoprotein diagnostic testing market to grow at a CAGR of 7.89% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunoprotein diagnostic testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Immunoprotein Diagnostic Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Beckman Coulter
  • DiaSorin
  • F. Hoffmann-La Roche
  • Siemens Healthineers

Other Prominent Vendors

  • Menarini Diagnostics
  • Abcam
  • Adaltis
  • Affymetrix
  • Agilent Technologies
  • Biomedical diagnostics
  • bioMerieux
  • Bio-Rad Laboratories
  • Bioo Scientific
  • Certest Biotec
  • Corgenix
  • CorisBioconcept
  • Coyote Bioscience
  • DML
  • EIKEN CHEMICAL
  • EKF Diagnostics
  • Enzo Life Sciences
  • EUROIMMUN
  • Fitzgerald Industries
  • Fujirebio Diagnostics
  • Gentian
  • Grifols
  • IBL International
  • Immunodiagnostic Systems
  • ImmunoDX
  • Instrumentation Laboratory
  • Kyowa Medex
  • Merck Millipore
  • Meridian Bioscience
  • NecLife
  • Operon - Inmuno & Molecular Diagnostics
  • ORGENTEC Diagnostika
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • QIAGEN
  • Quest Diagnostics
  • Quidel
  • Sekisui Diagnostics
  • SQI Diagnostics
  • Standard Diagnostics
  • Sysmex
  • Technopath Clinical Diagnostics
  • The Binding Site Group
  • Thermo Fisher Scientific
  • Tosoh Bioscience
  • Trinity Biotech
  • Tulip Diagnostics
  • Wako

Market driver

  • Increasing use of immunochromatography-based cassette kits or test strips
  • For a full, detailed list, view our report

Market challenge

  • Limited capability and high complexity of procedure
  • For a full, detailed list, view our report

Market trend

  • Growing focus on next-generation products
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Overview
  • Market size and forecast
  • Five forces analysis

PART 06: Segmentation by application

  • Overview
  • Infectious disease testing
  • Oncology and endocrinology testing
  • Autoimmune testing
  • Allergy testing

PART 07: Segmentation by end-user

  • Overview
  • Hospital and clinics
  • Diagnostic laboratories

PART 08: Segmentation by geography

  • Overview
  • Americas
  • EMEA
  • APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Growing focus on next-generation products
  • Increasing use of cloud-based solutions
  • Emergence of nanoparticle-based immunoassay for protein test

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

  • Beckman Coulter
  • DiaSorin
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Share of global immunoprotein diagnostic testing market in global immunoassay market 2016
  • Exhibit 02: Global immunoprotein diagnostic testing market: Overview 2016-2021
  • Exhibit 03: Global immunoprotein diagnostic testing market 2016-2021 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global immunoprotein diagnostic testing market: Overview of segmentation by application
  • Exhibit 06: Global infectious disease testing market 2016-2021 ($ billions)
  • Exhibit 07: Global oncology and endocrinology testing market 2016-2021 ($ billions)
  • Exhibit 08: Global autoimmune testing market 2016-2021 ($ billions)
  • Exhibit 09: Global allergy testing market 2016-2021 ($ billions)
  • Exhibit 10: Global immunoprotein diagnostic testing market: Overview of segmentation by end-users
  • Exhibit 11: Global immunoprotein diagnostic testing market: Buying criteria of end-users
  • Exhibit 12: Global immunoprotein diagnostic testing market: Overview of segmentation by geography
  • Exhibit 13: Immunoprotein diagnostic testing market in Americas: Overview
  • Exhibit 14: Immunoprotein diagnostic testing market in Americas 2016-2021 ($ billions)
  • Exhibit 15: Immunoprotein diagnostic testing market in EMEA: Overview
  • Exhibit 16: Immunoprotein diagnostic testing market in EMEA 2016-2021 ($ billions
  • Exhibit 17: Immunoprotein diagnostic testing market in APAC: Overview
  • Exhibit 18: Immunoprotein diagnostic testing market in APAC 2016-2021 ($ billions)
  • Exhibit 19: Prevalence of infectious diseases
  • Exhibit 20: Companies offering chromatographic tests
  • Exhibit 21: Automation products offered by vendors
  • Exhibit 22: Cost of immunoprotein diagnostic testing products developed by Beckman Coulter
  • Exhibit 23: Global immunoprotein diagnostic testing market: Competitive structure analysis 2016
  • Exhibit 24: Global immunoprotein diagnostic testing market: Participants 2016
  • Exhibit 25: Global immunoprotein diagnostic testing market: Strategic success factors of companies 2016
  • Exhibit 26: Beckman Coulter: Key highlights
  • Exhibit 27: Beckman Coulter: Strength assessment
  • Exhibit 28: Beckman Coulter: Strategy assessment
  • Exhibit 29: Beckman Coulter: Opportunity assessment
  • Exhibit 30: DiaSorin: Key highlights
  • Exhibit 31: DiaSorin: Strength assessment
  • Exhibit 32: DiaSorin: Strategy assessment
  • Exhibit 33: DiaSorin: Opportunity assessment
  • Exhibit 34: F. Hoffmann-La Roche: Key highlights
  • Exhibit 35: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 38: Siemens Healthineers: Key highlights
  • Exhibit 39: Siemens Healthineers: Strength assessment
  • Exhibit 40: Siemens Healthineers: Strategy assessment
  • Exhibit 41: Siemens Healthineers: Opportunity assessment
  • Exhibit 42: Abbott: Overview
  • Exhibit 43: Alere: Overview
Back to Top